NCT05530408 Quantitative Pulmonary Imaging Registry & Biorepository
| NCT ID | NCT05530408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | Pulmonary Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-05-24 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-05-24 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.
Eligibility Criteria
Inclusion Criteria: * The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT. Exclusion Criteria: * The participant declines to participate.
Contact & Investigator
Peter J Niedbalski, PhD
PRINCIPAL INVESTIGATOR
Research Assistant Professor
Frequently Asked Questions
Who can join the NCT05530408 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05530408 currently recruiting?
Yes, NCT05530408 is actively recruiting participants. Contact the research team at chernandez@kumc.edu for enrollment information.
Where is the NCT05530408 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT05530408 clinical trial?
NCT05530408 is sponsored by University of Kansas Medical Center. The principal investigator is Peter J Niedbalski, PhD at Research Assistant Professor. The trial plans to enroll 100 participants.